INSM

Latest SEC Filings & News for INSM

1 most recent filing and news item mentioning INSM. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/INSM/news?limit=20"

Pull INSM filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Insmed reports positive 12-month data for TPIP in PAH study.

Insmed announced sustained efficacy and safety for once-daily TPIP, strengthening the potential for the drug to become the prostanoid of choice for PAH patients. These data advance the company's clinical development pipeline.

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.